Market Overview:

Bone marker tests are performed to evaluate the health of the bone by measuring the number of bone markers in the body. Bone marker tests help to determine the metabolic bone diseases such as osteoporosis, Paget disease, etc.

Usually, bone diseases are the silent disease which might not display early symptoms, making bone marker tests important for their diagnosis such as risks of fractures. Four main bone markers are tested for evaluating the health of the bone, which are s-BALP, s-PINP, u-NTX, and s-ßCTX.

The time of sample collection significantly affects the result of the bone marker tests as few bone markers create false results in different times of the day. Currently, Working Group on Bone Marker Standards (WG-BMS), a joint effort by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the International Osteoporosis Foundation (IOF) are working to identify consensus reference standards for bone marker tests. Bone marker tests basically measure the rate of increase or decrease in the bone turnover marker that is bone reabsorbed or formation.

According to the International Osteoporosis Foundation, osteoporosis causes more than 8.9 million fractures each year globally. The incidence of osteoporotic fracture is very high, that is one every 3 seconds. Moreover, the worldwide incidence of fracture in men is estimated to witness growth by 310% and 240% in women, by 2050 as compared to rates in 1990. Such rapidly increasing incidences of bone diseases are expected to drive the bone marker test market with a high CAGR over the forecast period.

The risk of bone disease increases with multiple folds by the aging process. Therefore, the increasing geriatric population is considered to propel the demand for bone marker test market over the forecast years. More and more manufacturers are entering the bone marker test market and have their bone market tests with differentiating features under regulatory approval procedure pipeline.

On the contrary, lack of awareness about the importance of bone marker tests may hamper the rapid expansion of the bone marker test market over the forecast period.

Additionally, limited laboratory resources and infrastructure can become a restraint in the growth of the bone marker test market.

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Get FREE Report Sample

Market Segmentation:

Sample	Blood Urine
Product Type	Immunoassay Analyzer Systems Kits ELISA EIA Flow Assay Kit Radioimmunoassay
Bone Maker	s-BALP s-PINP u-NTX s-ßCTX Deoxypyridinoline Cross-Links (Dpd) Pyridinium Cross-Links (Pyd) Other
Application	Osteoporosis Osteopenia Osteopetrosis Paget Disease Bone Remodeling Hormone Monitoring Rickets Renal Osteodystrophy Other
End Users	Hospitals and Clinics Diagnostic Laboratories Reference Laboratories Research Institutes
Region	North America Latin America Europe East Asia South Asia Middle East & Africa Oceania